Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3573-0
Abstract: PurposeThis phase II study was performed to evaluate the efficacy and safety of cisplatin/pemetrexed combined with 15 mg/kg of bevacizumab followed by pemetrexed/bevacizumab maintenance therapy as first-line chemotherapy in advanced non-squamous non-small cell lung cancer (NSCLC)… read more here.
Keywords: maintenance therapy; egfr wild; maintenance; followed pemetrexed ... See more keywords
Anti-Yo paraneoplastic cerebellar degeneration in a patient with stage IV ovarian adenocarcinoma during bevacizumab maintenance therapy
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-251277
Abstract: Anti-Yo paraneoplastic cerebellar degeneration (PCD) is a rare autoimmune neurological syndrome characterised by cerebellar symptoms and frequently associated with gynaecological malignancies. While typically preceding the diagnosis of the malignancy, rarely it may present later in… read more here.
Keywords: ovarian adenocarcinoma; cerebellar degeneration; paraneoplastic cerebellar; bevacizumab maintenance ... See more keywords
EP769 Survival associated with first-line bevacizumab maintenance therapy among older patients with ovarian cancer: findings from the VIERA study
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-esgo.820
Abstract: Introduction/Background Bevacizumab with chemotherapy followed by bevacizumab was approved in 2018 for the first-line (1L) treatment of patients with ovarian cancer (OC). However, little is known about the real-world experience of OC patients treated with… read more here.
Keywords: first line; maintenance; study; bevacizumab maintenance ... See more keywords
Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of gynecologic oncology"
DOI: 10.3802/jgo.2023.34.e60
Abstract: OBJECTIVE Bevacizumab maintenance therapy following platinum-based combination chemotherapy for metastatic, recurrent, or persistent cervical cancer is not recommended as standard therapy. This pilot study aimed to evaluate the efficacy and safety of bevacizumab maintenance therapy… read more here.
Keywords: maintenance therapy; bevacizumab maintenance; chemotherapy; therapy ... See more keywords